Multiple Organ Dysfunction Syndrome clinical trials at UCSF

1 research study open to eligible people

Multiple organ dysfunction syndrome is when multiple organs in the body fail. UCSF is researching if anakinra can help children with organ problems caused by sepsis. The trial is organized across various centers and follows strict guidelines.

Showing trials for

  • Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

    open to eligible people ages up to 17 years

    The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in children with sepsis-induced multiple organ dysfunction syndrome (MODS).

    Oakland, California and other locations